Psychotropic Medication Compliance

Paper Summary:

This paper examines antipsychotic medication compliance among patients post discharge from a psychiatric acute care setting. It discusses the factors that can be attributed to noncompliance and aims to understand how they affect patient compliance. The paper then aims to develop a treatment model that can help patients become more compliant with their medication.

Table of Contents:
Abstract
Introduction
Review of Literature
Side Effects
Substance Abuse
History of Medication Noncompliance
Support System
Side Effects
Substance Abuse
History of Noncompliance
Conclusion

From the Paper:

"The inability to recognize clinical symptoms, lack of knowledge on the drugs' efficacy and how the treatment program is expected to affect the patient leads to noncompliance. The PNP will conduct educational programs to provide the mentally ill and the community with information concerning the disease's symptoms, the drugs and how they will treat the illness, and how a treatment program will progress through time. This requires constant repetition to overcome the paranoia that is common among schizophrenic patients. The PNP will also monitor outpatients' compliance by conducting regular visits to patients' houses when they have one. Or patients can choose to visit the clinics anytime."

Sample of Sources Used:

• Carrick, R., et al. (2004). The Quest for Well-Being: A Qualitative Study of the Experience of Taking Antipsychotic Medication. Psychology and Psychotherapy: Theory, Research and Practice, 77, 19-33.
• Chambers, R.A. et al. (2007). Neonatal Amygdala Lesions: Co-Occurring Impact on Social/Fear-Related Behavior and Cocaine Sensitization in Adult Rats. Behavioral Neuroscience, 121.
• Csernansky, J.G. (2000). Maintenance drug treatment for schizophrenia. Neuropsychopharmacology: The Fifth Generation of Progress. Retrieved December 3, 2008, from http://www.acnp.org/g4/GN401000122/CH.html
• Dolder, C.R., et al. (2002). Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents? American Journal of Psychiatry, 159, 103-108.
• Franklin, D.J. Schizophrenia and substance abuse. Psychology Information Online. Retrieved December 3, 2008, from http://www.psychologyinfo.com/schizophrenia/substanceabuse.html

More papers on Psychotropic Medication Compliance:

• Research Paper # 117993 : "Psychotropic Medications and Schizophrenia"
• Research Proposal # 61880 : "Medical Compliance"
• Research Paper # 149577 : "Neurotransmission and Psychotropic Treatment for OCD"

APA Citation:

MLA Citation: